The Risk of Abdominal Obesity according to the Degree of Non- Alcoholic Fatty Liver Disease in Korean Men

다국어 초록 (Multilingual Abstract)

Although non-alcoholic fatty liver disease has been reported as a cardiometabolic risk factor, the effect of non-alcoholic fatty liver is yet to be clarified on abdominal obesity.
Therefore, this study was conducted to investigate the longitudinal relationship of nonalcoholic fatty liver on the development of abdominal obesity. The study participants were composed of 11,212 Korean men without abdominal obesity. They were followed up from 2005 to 2010 to be monitored for the development of abdominal obesity according to their degree of non-alcoholic fatty liver disease (normal, mild, and moderate to severe).
Cox-proportional hazard model was used to calculate the hazard ratios for abdominal obesity according to the degree of non-alcoholic fatty liver disease. While the average incidence was 15.5%, the incidence of abdominal obesity increased according to the degree of non-alcoholic fatty liver (normal: 11.6%, mild: 25.2%, moderate to severe: 41.0%, P < 0.001). Multivariable-adjusted hazard ratios for abdominal obesity independently increased proportionally to the degree of NAFLD (mild [1.07; 0.94-1.23], moderate to severe [1.58; 1.11-2.26], P for trend < 0.001). The risk of abdominal obesity increased proportionally to the degree of non-alcoholic fatty liver disease. This finding guarantees further studies to reveal the incidental relationship of abdominal obesity with non-alcoholic fatty liver disease.

참고문헌 (Reference)

1 Anjana M, "Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians" 27 : 2948-2953, 2004

2 Nishiura T, "Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes" 78 : 189-197, 2005

3 Saadeh S, "The utility of radiological imaging in nonalcoholic fatty liver disease" 123 : 745-750, 2002

4 Mottin CC, "The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients" 14 : 635-637, 2004

5 Ryoo JH, "The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men : 5-year’s prospective cohort study" 227 : 398-403, 2013

6 Graif M, "Quantitative estimation of attenuation in ultrasound video images : correlation with histology in diffuse liver disease" 35 : 319-324, 2000

7 Bedogni G, "Prevalence of and risk factors for nonalcoholic fatty liver disease : the Dionysos nutrition and liver study" 42 : 44-52, 2005

8 World Health Organization, "Obesity and overweight"

9 Pagano G, "Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association" 35 : 367-372, 2002

10 Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis : summary of an AASLD Single Topic Conference" 37 : 1202-1219, 2003

11 Sanyal AJ, "Nonalcoholic steatohepatitis : association of insulin resistance and mitochondrial abnormalities" 120 : 1183-1192, 2001

12 Angulo P, "Nonalcoholic fatty liver disease" 346 : 1221-1231, 2002

13 McNay EC, "Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: a model for weight gain with intensive insulin therapy" 304 : E131-E138, 2013

14 Russell-Jones D, "Insulin-associated weight gain in diabetes--causes, effects and coping strategies" 9 : 799-812, 2007

15 Mathiesen UL, "Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases" 34 : 516-522, 2002

16 Mehran AE, "Hyperinsulinemia drives diet-induced obesity independently of brain insulin production" 16 : 723-737, 2012

17 Alberti KG, "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity" 120 : 1640-1645, 2009

18 Kelly T, "Global burden of obesity in 2005 and projections to 2030" 32 : 1431-1437, 2008

19 Scatarige JC, "Fatty infiltration of the liver : ultrasonographic and computed tomographic correlation" 3 : 9-14, 1984

20 Højgaard B, "Economic costs of abdominal obesity" 1 : 146-154, 2008

21 Hernaez R, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver : a meta-analysis" 54 : 1082-1090, 2011

22 Joy D, "Diagnosis of fatty liver disease: is biopsy necessary?" 15 : 539-543, 2003

23 Ruhl CE, "Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States" 124 : 71-79, 2003

24 Hung CH, "Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis" 38 : 153-157, 2003

25 Coutinho T, "Central obesity and survival in subjects with coronary artery disease : a systematic review of the literature and collaborative analysis with individual subject data" 57 : 1877-1886, 2011

26 Després JP, "Abdominal obesity and metabolic syndrome" 444 : 881-887, 2006